Regeneration and control of human fibroblast cell density by intermittently delivered pulsed electric fields

Proliferative scarring is a human disease with neither available effective treatment nor relevant animal model. One of the hypotheses for scar formation involves deregulation of fibroblast signaling and delayed apoptosis. Here, we introduce a new chemical‐free method for fibroblast density control in culture by intermittently delivered pulsed electric fields (IDPEF), which cause irreversible damage to cell membranes. Using 5–100 pulses with electric field strength of 150 V/mm, pulse duration 70 µs, and frequency of 1 Hz, we investigated the effects of PEF application on growth, death, and regeneration of normal human dermal fibroblasts in culture. We found that the fraction of fibroblasts that survive depends on the number of pulses applied and follows a Weibull distribution. We have successfully developed an IDPEF protocol that controls fibroblasts density in culture. Specifically, through application of IDPEF every 72 h for 12 days, we maintain a normal human dermal fibroblast density in the 3.1 ± 0.2 × 105–1.4 ± 0.2 × 105 cell/mL range. Our results suggest that IDPEFs may prove useful as a non‐chemical method for fibroblast density control in human wound healing. Biotechnol. Bioeng. 2013; 110: 1759–1768. © 2013 Wiley Periodicals, Inc.

[1]  H. L. M. Lelieveld,et al.  Food preservation by pulsed electric fields: from research to application. , 2007 .

[2]  Boris Rubinsky,et al.  A statistical model for multidimensional irreversible electroporation cell death in tissue , 2010, Biomedical engineering online.

[3]  A. Singer,et al.  Cutaneous wound healing. , 1999, The New England journal of medicine.

[4]  P. Scott,et al.  Deep dermal fibroblasts contribute to hypertrophic scarring , 2008, Laboratory Investigation.

[5]  Carolyn Compton,et al.  Control of hypertrophic scar growth using selective photothermolysis , 1997, Lasers in surgery and medicine.

[6]  Thomas J Webster,et al.  Electrically active nanomaterials as improved neural tissue regeneration scaffolds. , 2010, Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology.

[7]  Gustavo V. Barbosa-Cánovas Nonthermal preservation of foods , 1998 .

[8]  P. Butz,et al.  Extraction of anthocyanins from grape by-products assisted by ultrasonics, high hydrostatic pressure or pulsed electric fields: A comparison , 2008 .

[9]  D. Swann,et al.  A comparison of glycosaminoglycan synthesis by human fibroblasts from normal skin, normal scar, and hypertrophic scar. , 1985, The Journal of investigative dermatology.

[10]  Max E Valentinuzzi,et al.  Honoring Leslie A. Geddes - Farewell ... , 2010, Biomedical engineering online.

[11]  Damijan Miklavcic,et al.  Equivalent Pulse Parameters for Electroporation , 2011, IEEE Transactions on Biomedical Engineering.

[12]  Michael Belkin,et al.  Irreversible Electroporation for Microbial Control of Drugs in Solution , 2009, AAPS PharmSciTech.

[13]  M. Robson,et al.  Differential production of apoptosis-modulating proteins in patients with hypertrophic burn scar. , 1998, The Journal of surgical research.

[14]  Boris Rubinsky,et al.  Towards Electroporation Based Treatment Planning considering Electric Field Induced Muscle Contractions , 2012, Technology in cancer research & treatment.

[15]  Michael T. Longaker,et al.  Scarless Wound Healing , 2000, Principles of Regenerative Medicine.

[16]  E. Neumann,et al.  Gene transfer into mouse lyoma cells by electroporation in high electric fields. , 1982, The EMBO journal.

[17]  • Epidermis,et al.  WOUND healing. , 1959, The Medical journal of Australia.

[18]  R. Diegelmann,et al.  Wound healing: an overview of acute, fibrotic and delayed healing. , 2004, Frontiers in bioscience : a journal and virtual library.

[19]  Enrique Palou,et al.  Nonthermal preservation of foods. , 1997 .

[20]  Helen Kavnoudias,et al.  Investigation of the safety of irreversible electroporation in humans. , 2011, Journal of vascular and interventional radiology : JVIR.

[21]  M. Klinger,et al.  The most current algorithms for the treatment and prevention of hypertrophic scars and keloids. , 2010, Plastic and reconstructive surgery.

[22]  S. O'Kane,et al.  Transforming growth factor βs and wound healing , 1997 .

[23]  Micha Peleg,et al.  Advanced Quantitative Microbiology for Foods and Biosystems: Models for Predicting Growth and Inactivation , 2006 .

[24]  D. M. Cooper,et al.  Definitions and guidelines for assessment of wounds and evaluation of healing. , 1994, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[25]  A. Golberg MICROBIAL LOAD CONTROL BY INTERMITTENTLY DELIVERED PULSED ELECTRIC FIELDS , 2014 .

[26]  W. Border,et al.  Transforming Growth Factor β in Tissue Fibrosis , 1994 .

[27]  M. Robson Proliferative scarring. , 2003, The Surgical clinics of North America.

[28]  M. Longaker,et al.  Tamoxifen Downregulates TGF-β Production in Keloid Fibroblasts , 1998 .

[29]  Weifeng He,et al.  Investigating the Role of P311 in the Hypertrophic Scar , 2010, PloS one.

[30]  M. Longaker,et al.  Tamoxifen downregulates TGF-beta production in keloid fibroblasts. , 1998, Annals of plastic surgery.

[31]  Ashutosh Kumar Dubey,et al.  Optimization of electrical stimulation parameters for enhanced cell proliferation on biomaterial surfaces. , 2011, Journal of biomedical materials research. Part B, Applied biomaterials.

[32]  Andrew Leask,et al.  TGF‐β signaling and the fibrotic response , 2004, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[33]  W. Border,et al.  Transforming growth factor beta in tissue fibrosis. , 1994, The New England journal of medicine.

[34]  Francis Ko,et al.  Tamoxifen decreases fibroblast function and downregulates TGF(beta2) in dupuytren's affected palmar fascia. , 2002, The Journal of surgical research.

[35]  R. Sheridan,et al.  What's new in burns and metabolism. , 2004, Journal of the American College of Surgeons.

[36]  M. Hanasono,et al.  Effect of tamoxifen on transforming growth factor beta1 production by keloid and fetal fibroblasts. , 2001, Archives of facial plastic surgery.

[37]  E. Tredget,et al.  Stromal cell‐derived factor 1 (SDF‐1) and its receptor CXCR4 in the formation of postburn hypertrophic scar (HTS) , 2011, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[38]  J. Murray Scars and keloids. , 1993, Dermatologic clinics.

[39]  A. Sigal,et al.  Collective and single cell behavior in epithelial contact inhibition , 2011, Proceedings of the National Academy of Sciences.

[40]  Thomas A. Mustoe, MD, FACS Scars and keloids , 2004, BMJ : British Medical Journal.

[41]  M. Robson,et al.  Prevention and treatment of postburn scars and contracture , 2005, World Journal of Surgery.

[42]  Definitions and guidelines for assessment of wounds and evaluation of healing , 2002 .

[43]  M. Okino,et al.  Effects of a high-voltage electrical impulse and an anticancer drug on in vivo growing tumors. , 1987, Japanese journal of cancer research : Gann.

[44]  Michael T Longaker,et al.  Hypertrophic Scar Formation Following Burns and Trauma: New Approaches to Treatment , 2007, PLoS medicine.

[45]  S. Sukharev,et al.  In vivo electroporation and stable transformation of skin cells of newborn mice by plasmid DNA. , 1991, Biochimica et biophysica acta.

[46]  D. Foreman,et al.  Neutralisation of TGF-beta 1 and TGF-beta 2 or exogenous addition of TGF-beta 3 to cutaneous rat wounds reduces scarring. , 1995, Journal of cell science.

[47]  U. Zimmermann,et al.  Electric field-mediated fusion and related electrical phenomena. , 1982, Biochimica et biophysica acta.

[48]  Boris Rubinsky,et al.  Experimental Studies on Non-thermal Irreversible Electroporation in Tissue , 2010 .

[49]  D. Steed,et al.  Wound healing: biologic features and approaches to maximize healing trajectories. , 2001, Current problems in surgery.

[50]  R. Tompkins,et al.  Control of hypertrophic scar growth using antibody-targeted photolysis. , 1996, The Journal of surgical research.

[51]  L. Mir,et al.  Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. , 1988, Biochemical pharmacology.

[52]  B. Rubinsky,et al.  Intermittently Delivered Pulsed Electric Fields for Sterile Storage of Turbid Media , 2010, IEEE Transactions on Plasma Science.

[53]  W. Bement,et al.  Wound repair: toward understanding and integration of single-cell and multicellular wound responses. , 2011, Annual review of cell and developmental biology.

[54]  W. G.,et al.  Topical tamoxifen-a potential therapeutic regime in treating excessive dermal scarring ? , 2022 .

[55]  M. Robson,et al.  The 1997 Moyer Award. Cytokine production in patients with hypertrophic burn scars. , 1997, The Journal of burn care & rehabilitation.

[56]  Gerta Vrbová,et al.  Application of Muscle/Nerve Stimulation in Health and Disease , 2008 .

[57]  L. Mishra,et al.  Transforming growth factor-beta and wound healing. , 2006, Perspectives in vascular surgery and endovascular therapy.

[58]  Priya Kathirvel,et al.  Effect of Irreversible Electroporation on Cell Proliferation in Fibroblasts , 2011 .

[59]  H. Laverty,et al.  Prevention and reduction of scarring in the skin by Transforming Growth Factor beta 3 (TGFβ3): from laboratory discovery to clinical pharmaceutical , 2008, Journal of biomaterials science. Polymer edition.

[60]  A. Desmoulière,et al.  Apoptosis mediates the decrease in cellularity during the transition between granulation tissue and scar. , 1995, The American journal of pathology.

[61]  H. L. M. Lelieveld,et al.  Food preservation by pulsed electric fields , 2007 .

[62]  J. Weaver,et al.  Theory of electroporation: A review , 1996 .